Michael Carter II

Cornerback

Age: 26
Free Agency: 2028 (Void)
Accrued Seasons: 5
  • 2025 Salary Cap Charge: $1,203,056 (0.41% of cap)
  • 2025 Cash Payout: $1,203,056 (0.44% of spending)
  • 2025 Cash to Cap Ratio: 1.00
  • Contract Value: $30,750,000 ($10,250,000 APY)
  • Fully Guaranteed Money: $13,063,500
  • Contract Ranking: 29/303 at CB

Current Contract

(Extension, signed 2024)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryPer Game Roster BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202526$1,697,500$552,500$943,056$1,203,0560.4%
202627$9,697,500$552,500$1,384,000$10,120,0003.3%
202728$9,697,500$552,500$0$10,250,0003.3%
2028 📝
February 15: Contract voids 5th day waiver period
29VoidVoidVoid$00.0%
202930VoidVoidVoid$0--
203031VoidVoidVoid$0--
Total$21,092,500$1,657,500$2,327,056$21,573,056

Contract Notes

Michael Carter II signed a 3 year extension with the New York Jets worth $30.75 million in new money with $18.046 million in total guarantees including a $6 million signing bonus and a $4 million option bonus in 2025. The contract includes 4 void years for salary cap purposes.

Cash Flows

- old money
- fully earned money
- unearned or partially earned money
$10.3M
$20.5M
$30.8M
Old Money202520262027
Cash Due$4,000,000$6,250,000$10,250,000$10,250,000
Running Cash$10,250,000$20,500,000$30,750,000
Career Earnings: $16,239,928
Career APY: $3,247,986
Potential Earnings: $31,822,984
Total Guarantees: $26,455,928
Largest Cash Payment: $10,250,000 (2026)
Largest Cap Number: $10,250,000 (2027)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
JetsDraftedExtended20214$3,808,928$952,232$328,928$2,753,92872.3%$917,976
JetsExtensionTraded20243$30,750,000$10,250,000$13,063,500$7,366,00024.0%$7,366,000
EaglesExtensionActive20243$30,750,000$10,250,000$13,063,500$1,203,0563.9%$1,203,056
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Jets4$15,036,872$3,759,218$5,319,9280.0%$9,716,9440.0%
Eagles1$1,203,056$1,203,056$1,203,0560.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusPer Game Roster BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2021Jets$660,000$82,232$0$0$742,2320.4%$988,928
2022Jets$825,000$82,232$0$0$907,2320.4%$825,000
2023Jets$940,000$82,232$0$0$1,022,2320.4%$940,000
2024Jets$1,366,000$1,282,232$0$1,366,000$2,648,2321.0%$7,366,000
2025Eagles$1,697,500$0$552,500$943,056$1,203,0560.4%$1,203,056
2026Eagles$9,697,500$0$552,500$1,384,000$10,120,0003.3%$10,250,000
2027Eagles$9,697,500$0$552,500$0$10,250,0003.3%$10,250,000
2028Eagles$1,390,000$0$0$0$00.0%$0
2029Eagles$1,435,000$0$0$0$0--$0
2030Eagles$40,000,000$0$0$0$0--$0
Total$67,708,500$1,528,928$1,657,500$3,693,056$26,892,984$31,822,984
Dead Money History
TeamYearCap ChargeCash Paid
Jets2025$2,916,944$4,916,944
Jets2026$6,800,000$0
Total$9,716,944$4,916,944

Statistics

YearGames PlayedGames InactiveSnapsTacklesNegative PlaysInterceptionsFumblesTD
DefenseSpecialSoloAssistSacksYardsTFLQB HitsPass Def.INTYardsForcedRec.Yards
202117172.2%29.1%442715425000200
202216059.9%7.8%491300309200000
202315259.0%1.6%371300119001000
202413421.6%10.4%20400101000100
202513422.2%16.3%121100102000000

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$1,860,000$10,250,000
Injury Adjusted$1,860,000$10,250,000
test
OTC Valuation $4M $8M $12M $15.9M $19.9M APY $5M $10M $15.1M $20.1M $25.1M $8,918,000 $5,500,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.